Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo.
Halder
R M
RM
Battle
E F
EF
Smith
E M
EM
D000279:Administration, Cutaneous; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008297:Male; D008730:Methoxsalen / Q000008:administration & dosage / Q000009:adverse effects; D008875:Middle Aged; D011701:PUVA Therapy / Q000009:adverse effects*; D012878:Skin Neoplasms / Q000139:chemically induced*; D014307:Trioxsalen / Q000008:administration & dosage / Q000009:adverse effects; D014820:Vitiligo / Q000188:drug therapy*
D008730:Methoxsalen; D014307:Trioxsalen